Mersana Therapeutics, Inc. (MRSN)
Q2 2020 Earnings Conference Call
August 7, 2020 8:00 AM ET
Company Participants
Sarah Carmody – Executive Director, Investor Relations and Corporate Communications
Anna Protopapas – President and Chief Executive Officer
Tim Lowinger – Chief Science and Technology Officer
Brian DeSchuytner – Senior Vice President Finance and Product Strategy
Conference Call Participants
Jonathan Chang – SVB Leerink
Boris Peaker – Cowen
Tom Shrader – BTIG
Mike Ulz – Baird
Presentation
Operator
Good morning, and welcome to Mersana Therapeutics' Second Quarter 2020 Conference Call. [Operator Instructions]
I would now like to turn